Ashton LJ et al. HIV infection in recipients of blood products from donors with known duration of infection. Lancet 344:718-720, 1994.

Barnett SW et al. An AIDS-like condition induced in baboons by HIV-2. Science 266:642-646, 1994.

Becherer PR et al. Human immunodeficiency virus-1 disease progression in haemophiliacs. Am J Hematol 34(3):204-209 , 1990.

Burke DS et al. Measurement of the false positive rate in a screening programme for human immunodeficiency virus infection. NEJM 319:961-964, 1988.

Chattopadhya D et al. Antimalarial antibody in relation to seroreactivity for HIV infection in sera from blood donors. Journal of Communicable Diseases 23(3):195-198, 1991.

CDC. Update: acquired immunodeficiency syndrome in the San Francisco cohort study, 1978-1985. MMWR 34:573-575, 1985.

Curran JW et al. The epidemiology of AIDS: current status and future prospects. Science 229:1352-1357, 1985.

Chelucci C et al. PCR analysis of HIV-1 sequences and differential immunological. features in seronegative and seropositive haemophiliacs. Br J Haematology 81:558-567, 1992.

Cuthbert RJ et al. Immunological studies in HIV seronegative haemophiliacs: relationships to blood product therapy. Br J Haematology 80:364-369, 1992.

Darby SC et al. Mortality before and after HIV infection in the UK population of haemophiliacs. Nature 377:79-82, 1995.

De Biasi R et al. The impact of a very high purity factor VIII concentrate on the immune system of human immunodeficiency virus-infected haemophiliacs: a randomized, prospective, two-year comparison with an intermediate purity concentrate. Blood 78(8):1919-1922, 1991.

Duesberg P. AIDS acquired by drug consumption and other noncontagious risk factors. Pharmac Ther 55:201-277, 1992.

Duncan R et al. Idiopathic CD4+ T-lymphocytopenia four patients with opportunistic infections and no evidence of HIV infection. NEJM 328(6):393-398, 1993.

Ellenberger DL et al. Viral and immunological examination of human immunodeficiency virus type 1-infected, persistently seronegative persons. Journal of Infectious Diseases 180(4):1033-1042, 1999.

Gjerset GF et al. Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disorders. Blood 78(6):1623-1627, 1991.

Gjerset GF et al. Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Blood 84(5):1666-1671, 1994.

Harris SB. The AIDS heresies: A case study in skepticism taken too far. Skeptic 3(2):42-79, 1995

Hassett J et al. Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. Blood 82(4):1351-1357, 1993.

Hishida O et al. Clinically diagnosed AIDS cases without evident association with HIV type 1 and 2 infections in Ghana. Lancet 340:971-972, 1992.

Ho DD et al. Idiopathic CD4+ T-Lymphocytopenia immunodeficiency without evidence of HIV infection. NEJM 328(6):380-385, 1993.

Holmberg SD et al. Biologic factors in the sexual transmission of human immunodeficiency virus. JID 160(1):116-125, 1989.

Kroner BL et al. HIV-1 infection among persons with haemophilia in the United States and Western Europe, 1978-1990. JAIDS 7:279-286, 1994.

Levy JA et al. Pathogenesis of human immunodeficiency virus infection. Microbiological Reviews 57:185-289, 1993.

Ludlam CA et al. Human lymphotropic virus type III, HTLV-III. infection in seronegative haemophiliacs after transfusion of Factor VIII. Lancet i(8449):233-236, 1985.

Mackenzie WR et al. Multiple false-positive serologic tests for HIV, HTLV-1 and hepatitis C following influenza vaccination, 1991. JAMA 268(8):1015-1017, 1992.

Madhok R et al. Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus. BMJ 293:978-980, 1986.

Novembre FJ et al. AIDS in a chimpanzee infected with HIV-1. Third Conference on Retroviruses and Opportunistic Infections, Washington, abstract 211, 1996.

Papadopolous-Eleopolous E et al. Is a positive Western Blot proof of HIV infection? Biotechnology 11: June 1993.

Ranki A et al. Interpretation of antibodies reacting solely with human retroviral core proteins. NEJM 318:448-449, 1988.

Schechter MT et al. HIV-1 and the aetiology of AIDS. Lancet 341:658-659, 1993.

Sheppard H et al. CD4+ lymphocytopenia without HIV infection. NEJM 328(25):1847-1850, 1993.

Sloande E et al. HIV testing: state of the art. JAMA 266(20):861-866, 1991.

Van den Berg H et al. Ten years after acquiring an HIV-1 infection: a study in a cohort of eleven neonates infected by aliquots from a single plasma donation. Acta Paediatr. 83(2):173-178, 1994.

Williams CKO et al. AIDS-associated cancers .In Essex M et al. Eds 'AIDS In Africa', Raven Press, 325-371, 1994.

Zaccarelli M et al Impact of HIV infection on non-AIDS mortality among Italian injecting drug users. AIDS 8 (3):345-350, 1994.